Meredith was upgraded to buy from hold at TheStreet Ratings on Wednesday. TheStreet Ratings gives Meredith a B- grade and $37.54 price target.
With the presidential debate on the horizon, analysts are speculating how the healthcare industry could be impacted by either candidate.
Rural hospital operators have already been implicated, but the review is pushing down other services companies too far and may present buying opportunities.
Activists could take interest in the challenged group of non-urban hospital operators as they continue to disappoint investors.
Community Health looks like a logical LBO candidate with shares having lost significant value since completing its spin off of Quorum Health in April.